Chiasma

YTD

ALL

Why Robinhood?

You can watch Chiasma and buy or sell other stocks, ETFs, and their options commission-free!

About CHMA

Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company's Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver.

CEO

Raj Kannan, MBA

CEORaj Kannan, MBA

Employees

—

Employees—

Headquarters

Newton Center, Massachusetts

HeadquartersNewton Center, Massachusetts

Founded

2001

Founded2001

Employees

—

Employees—

CHMA Key Statistics

Market cap

237.81M

Market cap237.81M

Price-Earnings ratio

-2.35

Price-Earnings ratio-2.35

Dividend yield

—

Dividend yield—

Average volume

1.23M

Average volume1.23M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$5.74

52 Week high$5.74

52 Week low

$2.77

52 Week low$2.77